Search - tctmd.com

Displaying 81 - 100 of 617

Sort: Relevancy | Date

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

News Conference News TCT 2024

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

Yael L. Maxwell

October 30, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Presenter: Lei Song

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH)

Presenter: Jung-Min Ahn

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Akiko Maehara

October 30, 2024

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Vinayak Bapat

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Neil Fam

October 30, 2024

Presentation TCT 2024

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Presenter: Brian Whisenant

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Presenter: Charles Davidson

October 30, 2024

Presentation TCT 2024

Editorial Comments

Presenter: Mamas Mamas

October 30, 2024

Presentation TCT 2024

Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization

Presenter: Birgitte Krogsgaard Andersen

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Presenter: Paul Sorajja

October 30, 2024

Presentation TCT 2024

Contact Intravascular Lithotripsy for Treating Complex Calcific Coronary Lesions: Six-Month and OCT Procedural Imaging Outcomes of the PINNACLE I Clinical Trial

Presenter: Johan Bennett

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Advertisement

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Preprocedural AI-QCA Matches OCT-Guided PCI for Noncomplex Lesions

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH)

Editorial Comments

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Editorial Comments

Editorial Comments

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Editorial Comments

Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Contact Intravascular Lithotripsy for Treating Complex Calcific Coronary Lesions: Six-Month and OCT Procedural Imaging Outcomes of the PINNACLE I Clinical Trial

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content